Lead Product(s) : Cephalosporin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Lafrancol | Prolab SA | Clínica Del Prado | Clínica Comfamiliar Pereira
Deal Size : Inapplicable
Deal Type : Inapplicable
Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy
Details : Cephalosporin is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Cellulitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 16, 2019
Lead Product(s) : Cephalosporin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Lafrancol | Prolab SA | Clínica Del Prado | Clínica Comfamiliar Pereira
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cephalosporin
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
Details : Cephalosporins is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Kidney Calculi.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 19, 2015
Lead Product(s) : Cephalosporin
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cephalosporin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)
Details : Cephalosporin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cystitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 06, 2012
Lead Product(s) : Cephalosporin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
